'Peoples' Hope' Remdesivir Results Due Soon - What To Look For?
Other Candidates Disappointing
The first data readout for remdesivir, the much anticipated antiviral for the coronavirus pandemic, is expected in days. Scrip surveys antiviral development and regulatory experts to gauge their interest and the key aspects to watch for in the milestone announcement.
